Major pharmaceutical companies are cautioning that Germany's plans to impose higher mandatory discounts for insurers, aimed at saving €12 billion by 2030, will ultimately backfire.

Prime Minister Narendra Modi has called upon Indian pharmaceutical companies to strive for a position among the world's top five.

A fierce global battle is underway among European, American, and Chinese pharmaceutical companies to dominate the obesity treatment market. Novo Nordisk CEO Doustdar believes that no single player will monopolize this rapidly growing sector.

A federal audit in Switzerland has revealed that hospitals are not consistently passing on discounts received from pharmaceutical companies and medical device manufacturers to patients. This failure means patients are paying more than they should for healthcare services.

An analysis explores the energy and pharmaceutical companies that are funding HDV's 3% yield, assessing the safety of each investment.

A summary of notable healthcare news for the week highlights developments concerning major pharmaceutical companies Eli Lilly, Novo Nordisk, and Pfizer.

Gorenje, pharmaceutical companies, and energy traders are identified as the largest exporters in Slovenia. These sectors are significant contributors to the nation's export economy.

An analysis highlights a particular stock that is significantly outperforming pharmaceutical giants Eli Lilly, Johnson & Johnson, and AbbVie. The article likely delves into the reasons for its strong performance.

Pharmaceutical companies AbbVie and Genmab have announced a setback in a late-stage clinical trial for their lymphoma therapy. This development could impact the future availability and development of the treatment.

The financial reform of statutory health insurance has been decided. Pharmaceutical companies like Boehringer Ingelheim feel betrayed. However, prices are also increasingly regulated elsewhere.

A commentary discusses whether the state prioritizes supporting "assembly lines" for pharmaceutical companies through clinical trials or genuinely helping patients, questioning the communication of state priorities.

A trend of major pharmaceutical companies investing in psychedelic drugs is emerging, with Eli Lilly making a significant deal worth up to $3.8 billion with AtaiBeckley, signaling a potential buyout spree in the sector.

Hospitals and doctors in the Netherlands have received millions of euros from pharmaceutical companies, with these payments showing a renewed increase.

An article recommends two specific pharmaceutical companies as fast-growing stocks that investors might consider buying.

Vice President of the Government and MP for the Northern Sector, Hatzidakis, along with Kyranakis, visited the facilities of DEMO ABEE, Win Medica (ELPEN Group), and FARAN in Tripoli to review strategic investments by these pharmaceutical companies.

An interview with Gundars Skudriņš, a medicinal plant grower, highlights his extensive farm covering over 600 hectares, primarily producing dried herbs for export to pharmaceutical companies.

Several non-pharmaceutical companies are identified as potential beneficiaries of the growing GLP-1 drug trend, indicating a broader economic impact beyond the pharmaceutical sector.

The Association of Pharmaceutical Companies of Greece (SFEE) played a leading role at the BEYOND 2026 international technology and innovation exhibition, hosting three high-level panels on health innovation.

With a rebound in mergers and acquisitions (M&A) activity, an article provides guidance on how pharmaceutical companies can prepare to successfully seal deals.

Top bankers indicate that while the biotech IPO window is beginning to open, mergers and acquisitions by large pharmaceutical companies remain the primary driver of dealmaking, fueled by the need to replenish drug pipelines ahead of patent expirations.

This article highlights notable healthcare news from the past week, bringing attention to developments involving pharmaceutical companies GSK, Parabilis Medicines, and Novo Nordisk.

Pharmaceutical companies Roche and Nurix Therapeutics have announced a collaboration and licensing agreement worth up to $2.3 billion to develop and commercialize new treatments for blood cancer.

The Greek Red Cross and the Association of Pharmaceutical Companies of Greece (SFEE) have partnered for the 'proSFEERoume' social initiative in Lefkada, aiming to support and promote health.

An analysis compares Bristol Myers and Pfizer to determine which of the two pharmaceutical companies offers a better high-yield dividend stock investment.

Eli Lilly, one of the world's largest pharmaceutical companies, is set to mark its 150th anniversary in 2026, reflecting on a century and a half of history in medicine.

Hundreds of doctors at major public hospitals in Copenhagen are engaged in extensive side jobs at private hospitals or pharmaceutical companies, raising concerns among patient organizations about potential conflicts of interest.

The Greek Red Cross (EES) and the Association of Pharmaceutical Companies of Greece (SFEE) have joined forces once again through the 'proSFEERoume' social initiative to support and promote health for vulnerable social groups in Lefkada.

Six biopharmaceutical companies and academic teams are currently working on developing antivirals, monoclonal antibodies, and vaccines to combat various strains of hantavirus.

During a parliamentary session, Greek MP Pavlos Polakis criticized pharmaceutical companies, stating that the "innovation fund" leads to increased profits for them and highlighting the problem of clawback.

Indian pharmaceutical companies are reportedly fueling a severe opioid and 'zombie drug' addiction crisis across Africa, particularly in West Africa. This issue persists despite ongoing crackdowns aimed at curbing the illicit drug trade.

Experts are raising concerns about direct-to-consumer pharmaceutical companies using memes and clear messaging to target young men with erectile dysfunction medication ads on social media, noting that many may not actually need the drugs.

As pharmaceutical companies develop more potent obesity drugs, new studies are being published to investigate their potential effects on bone density. This research aims to understand the broader health implications of these medications.

A report claims that a bill from the Greek Ministry of Health was ordered by the US Embassy. It alleges that Ms. Gilfoyle promised US interests she would pressure ministers, citing US pharmaceutical companies' profit losses from clawback policies.

The French drug safety agency ANSM has fined pharmaceutical companies Novo Nordisk and Eli Lilly for advertisements related to weight management drugs in France.

Successful negotiations between the Greek public sector and pharmaceutical companies have ensured that no immunotherapies will be withdrawn from Greece in 2026.

The FDA has proposed excluding weight loss drugs from Novo and Lilly from the bulk compounding list, a move that would benefit the pharmaceutical companies.

Following a record-breaking year, global pharmaceutical companies are actively seeking more biotechnology deals and partnerships within China's burgeoning biotech sector.

Advances are transforming cancer treatment, but questions are being raised about whether major pharmaceutical companies can afford to implement these revolutionary changes. The financial implications of new therapies pose a significant challenge for the industry.

Pharmaceutical companies in the UAE are taking steps to ensure a consistent and steady supply of medicines across the country.

Argentina has developed a more affordable biosimilar version of a leading cancer drug, a move attributed to strict patent regulations that are now being observed by pharmaceutical companies and states globally.

China has announced the suspension of colchicine imports from two specific Indian pharmaceutical companies, citing undisclosed reasons.

Health insurers are raising questions about a new Medicare program that will offer GLP-1 medications to seniors for $50 per month, leading to a drop in shares for pharmaceutical companies like Novo Nordisk and Eli Lilly amid concerns over coverage plans.

The Hellenic Association of Pharmaceutical Companies (SFEE) has launched "Innovation Meets Industry," a new strategic platform aimed at enhancing innovation within the pharmaceutical sector in Greece.

Major pharmaceutical companies are focusing on smaller deals, a strategic shift that is proving advantageous for the biotechnology sector.

Major pharmaceutical companies are increasingly turning their attention to China as a source for the newest drug ideas and innovations.

The Hellenic Association of Pharmaceutical Companies (SFEE) expressed deep concern and disappointment over the disregard of its positions and arguments regarding the significant clawback policy.

Pharmaceutical companies in Portugal are reportedly considering withdrawing from Valormed, the entity responsible for managing needle and lancet waste. This comes as the Environment Agency states Valormed is not meeting European targets, potentially suspending the creation of a new management entity.

Poolbeg Pharma's CEO stated that the recent patent win for POLB-001 significantly strengthens the company's potential for partnerships with major pharmaceutical companies.

FBI Director Kash Patel announced a major crackdown, 'Operation Box Cutter,' which has led to the indictment of Chinese pharmaceutical companies for allegedly supplying fentanyl precursors to the Gulf cartel.

This week's notable healthcare headlines focus on key developments concerning pharmaceutical companies such as Eli Lilly, Novo Nordisk, and Novartis.

Startups are actively working on commercial space stations, envisioning opportunities for pharmaceutical companies and wealthy tourists following the International Space Station's retirement in 2030.

For the fourth consecutive year, pharmaceutical companies UNI-PHARMA and InterMed have been certified as Top Employers 2026 in Greece by the independent international organization Top Employers Institute.

Mainland Chinese investors can now buy shares in more than a dozen newly added Hong Kong-listed biotech and pharmaceutical companies after a reshuffle of the Stock Connect southbound trading list took effect on Monday, reflecting the sector’s growing role on the international stage. Foreign capital, however, remained cautious, analysts said. “Mainland buyers have been the main force behind the latest healthcare rally. They tend to chase smaller-cap names where a tight free float makes it easi...

A report highlights notable healthcare headlines for the week, focusing on developments related to pharmaceutical companies Viatris, Novo Nordisk, and Gilead Sciences.

The European market is experiencing an influx of medicines produced in Asia, particularly from China, which poses a significant threat to drug security and creates growing competition for European pharmaceutical companies, including those in Poland.

The FDA has released new guidance aimed at speeding up the development process for pharmaceutical companies working on treatments for rare diseases, potentially benefiting the sector.

The Greek Ministry of Health and pharmaceutical companies are expected to present their arguments before the justice system regarding the rebate and clawback mechanisms for drugs administered in the adult obesity treatment program.

An analysis is being conducted to determine if the deal between BeOne Medicines AG (ONC) and Revolution Medicines (RVMD) represents a mutually beneficial outcome for both pharmaceutical companies.

An analysis delves into the broken economics behind high prescription drug prices in the United States, arguing that medicine will remain unaffordable if pricing is solely determined by pharmaceutical companies.

A federal audit in Switzerland has revealed that hospitals are not consistently passing on discounts received from pharmaceutical companies and medical device manufacturers to patients, leading to higher healthcare costs for consumers.

Pharmaceutical companies in Greece will provide discounts on the prices of innovative medicines for adult obesity, which were distributed for free under a government program. The discounts will apply to the entire program, not just specific months.

Relations between the Greek Ministry of Health and multinational pharmaceutical companies are at an impasse due to exorbitant mandatory clawback payments on hospital drugs and proposed legislative changes that are expected to exacerbate the issue.

Large pharmaceutical companies are acquiring biotechnology firms at an unprecedented rate, aiming to bolster their drug portfolios and utilize profits from successful products.

An investigation revealed that while data centers use significant quantities of water annually, pharmaceutical companies often consume even more.

Officials conducted a raid on a house in Dehradun, Uttarakhand, seizing counterfeit medicines bearing the names of reputable pharmaceutical companies, along with packaging materials and machinery.

The biotechnology sector is experiencing a record surge in deals as major pharmaceutical companies, concerned about expiring patents on lucrative drugs, aggressively pursue new blockbuster medicines.

An analysis provides recommendations on whether to buy, sell, or hold stocks in three of the largest pharmaceutical companies.

Chinese pharmaceutical companies with global ambitions are struggling to recruit sufficient staff, as the rapid growth of the country's experimental medicine testing industry outpaces its ability to build a global workforce.

Ems-Chemie, a plastics manufacturer whose main clients are struggling automakers, has seen its operating margin rise to over thirty percent for the first time, surpassing the profitability of Basel's pharmaceutical companies.

Major pharmaceutical companies are seeing gains as the U.S. government considers reducing discounts under the 340B drug pricing program.

Notable healthcare headlines for the week put Merck, AbbVie, and Bayer in focus, indicating significant developments within these pharmaceutical companies.

Several pharmaceutical companies, including Eli Lilly, Novo Nordisk, and Novartis, are being highlighted as leading investment opportunities in the longevity and anti-aging sector. These companies are recognized for their potential in developing treatments and technologies aimed at extending lifespan and combating aging.

Geneticist Scott Lowe emphasizes the need for government funding in science, acknowledging that while pharmaceutical companies contribute, their primary motivation is profit. He discusses advancements and challenges in cancer research.

Scientists, pharmaceutical companies, and funding bodies worldwide are actively working to develop and safely test new vaccines and treatments in response to ongoing Ebola outbreaks.

US pharmaceutical company Moderna is looking to invest in Germany and has shown interest in acquiring facilities belonging to its former competitor, BioNTech, while also calling for improved conditions for pharmaceutical companies.

The Tsetis Group of Pharmaceutical Companies actively contributed to the 2nd Arab-Hellenic Conference on Health, held in Athens on June 10 and 11, 2026, fostering cooperation in the health sector.

Pharmaceutical companies are intensifying efforts to enter the lucrative obesity drug market, currently dominated by Novo Nordisk and Eli Lilly, as they seek to develop the next generation of treatments.

SK Biopharmaceuticals has opened an innovation space in the United States to support Korean biotech and pharmaceutical companies in their global expansion efforts.

Forbes reports that pharmaceutical companies' risk registers often misclassify their most significant third-party exposures, potentially leading to overlooked vulnerabilities.

Japanese medical societies and pharmaceutical companies are issuing warnings against the use of the Type 2 diabetes drug Mounjaro for weight loss purposes, citing potential health risks despite its promotion on social media and by beauty clinics.

Global pharmaceutical companies are increasingly turning to China as patents on best-selling medicines expire, leading to growing US reliance on Chinese biotechs and prompting national security fears.

Swiss health insurance premiums could increase by 5 percent as pharmaceutical companies and the federal government dispute proposed savings measures for medication costs.

A new report suggests that weight-loss medications produced by pharmaceutical companies Lilly and Novo Nordisk may have an unexpected benefit, showing a link to the stalling of cancer progression.

A report reveals that pharmaceutical companies in Portugal take nine months to submit new medicines for evaluation, while Infarmed, the national health authority, takes an additional 11 months to decide on their funding, impacting access to new treatments.

The Hellenic Association of Pharmaceutical Companies (SFEE), in collaboration with Industry Disruptors – Game Changers (ID-GC), held the second roundtable of their strategic initiative "Innovation Meets Industry," focusing on investments, startups, and innovation in healthcare.

Greek Health Minister Adonis Georgiadis dismissed claims of pressure from US pharmaceutical companies regarding the creation of an Innovation Fund, calling them "conspiracy theories" during a parliamentary discussion.

Concerns are being raised about the excessive profits of pharmaceutical companies, alongside criticism that hospitals are severely understaffed, with one hospital handling over 100,000 emergency cases with only two pathologists.

Bristol Myers Squibb and China's Hengrui Pharma have signed a licensing deal valued at up to $15.2 billion. This agreement involves a significant collaboration between the two pharmaceutical companies.

A drug regulator has instructed pharmaceutical companies to submit safety reports for new drugs starting from their actual launch date, aiming to enhance post-market surveillance.

The PatientView™ annual global survey, 'The Corporate Reputation of Pharma' 2025/2026, reveals how patient support influences the reputation of pharmaceutical companies, based on responses from 2,403 patient groups.

French regulators have issued fines to pharmaceutical companies Novo Nordisk France and Lilly France for advertising anti-obesity treatments to the general public, which is prohibited under French law.

An analysis provides insights into the performance and outlook of several pharmaceutical giants, highlighting Bristol Myers' legacy boost, Biogen's positive prospects, and Regeneron's uncertain future.

Pharmaceutical companies Lilly and Novo Nordisk saw their stock prices increase following a proposal from the FDA to exclude GLP-1 receptor agonists from the compounding list.

The FTSE 100 index closed lower, primarily impacted by the struggles and declining share prices of major pharmaceutical companies GSK and AstraZeneca.

Chinese drug maker WuXi AppTec announced record first-quarter revenue, driven by a robust order backlog and sustained demand from pharmaceutical companies worldwide. The company's growth was supported by its strong global market presence.

Dozens of UK Members of Parliament are opposing Health Secretary Wes Streeting's move to grant himself power to dictate NHS drug prices, raising concerns about legality and potential benefits for big pharmaceutical companies.

Beijing Tongren Hospital has sold an ophthalmic dataset to pharmaceutical companies, indicating a trend in data monetization within the healthcare sector.

Pharmaceutical companies Teva and NeuroGen have announced a partnership to develop and distribute a migraine drug in the Chinese mainland market.

Pharmaceutical companies Merck and Eisai have encountered a setback in a late-stage clinical trial for their Keytruda regimen, intended for the treatment of kidney cancer.

Germany is reportedly losing a significant portion of newly approved drugs to the USA, with pharmaceutical companies preferring to launch new therapies there due to the financial impact of health reforms in Germany.

Pharmacists in Malaysia are urging for the establishment of buffer stocks and increased local production to ensure the nation's medicine supply, following new reporting requirements for pharmaceutical companies.

A conflict has emerged in Portugal between the Environment Agency (APA) and pharmaceutical companies regarding the disposal of medical needle waste. The industry claims the situation blocks operations and risks a company's viability, while APA defends its legal framework.

The European Union has granted approval for the $4.8 billion merger between US pharmaceutical companies BioMarin and Amicus, clearing a major regulatory hurdle for the deal.

Major pharmaceutical companies involved with COVID vaccines were compelled to discontinue a new research study because of insufficient participant enrollment.

Cross-border outlicensing activities by Chinese biotech firms reached a record US$60 billion in the first quarter of 2026, driven by multinational pharmaceutical companies' growing interest in the country's promising drug candidates.

Indian pharmaceutical companies are pursuing an aggressive strategy to enter European markets with generic products, capitalizing on Europe's push for greater autonomy in drug supply, according to Aneta Grzegorzewska of Ged.

An official from the Federal Trade Commission (FTC) stated that the agency is monitoring how major pharmaceutical companies are reacting to upcoming patent expirations.

Swiss-based Syngenta announced plans to build a new $120 million agricultural science center in the UK, an investment that contrasts with pharmaceutical companies withdrawing funding from British research facilities.

International pharmaceutical companies are expanding their operations and presence in the United States, a strategic move influenced by the looming threat of tariffs.

Hong Kong-listed mainland Chinese pharmaceutical companies are projected to achieve full-year profits, driven by increasing drug sales and successful out-licensing deals with global partners.

Poland's Ministry of Health is advocating for drug sovereignty by supporting the refunding of domestically produced medicines and offering incentives to pharmaceutical companies that relocate production to Poland, aiming to enhance drug security.

Delays in pricing and reimbursement processes continue to negatively affect the revenue streams of biopharmaceutical companies.

An expert suggests that the future growth of major pharmaceutical companies may increasingly depend on advancements in Chinese science, stating that 'We Can't Ban Our Way Out of This'.

This article discusses the potential outcomes for AbbVie Inc. as Genmab A/S encounters a new regulatory challenge concerning their drug Epcoritamab. It analyzes the implications for both pharmaceutical companies.

YIT Lietuva, a sustainable urban and infrastructure development company, announced that its 'Sky Office' business center in Vilnius has reached 100% occupancy, with technology and pharmaceutical companies securing the remaining spaces.

A report by financial control reveals that doctors, hospitals, and pharmacists in Switzerland are collecting 360 million Swiss francs in drug discounts from pharmaceutical companies, which should rightfully belong to patients or health insurers. This practice is still widely considered a minor offense within the industry.

A growing number of Swiss pharmaceutical companies are establishing operations in North Carolina, indicating a trend of international expansion and investment in the US market.

Major global pharmaceutical companies are significantly increasing their investments in China's rapidly expanding biotech sector, citing its substantial potential for innovation and valuation growth.

This week's notable healthcare headlines highlight developments concerning pharmaceutical companies Curium, Bristol-Myers Squibb, and Johnson & Johnson.

Pharmaceutical companies Johnson & Johnson and Gilead Sciences were among those receiving drug recommendations from the European Union this week. These recommendations are part of the EU's regulatory process for new and existing medicines.

Indian pharmaceutical companies are expressing significant concern and uncertainty following former President Donald Trump's proposal to impose tariffs, potentially up to 200%, on generic drug imports. Trump stated that non-patented drugmakers would have two years to move production to the U.S. or face a 100% import tariff, which would double a year later, severely impacting India's dominant position in the global generic drug market. Meanwhile, a Portuguese article discusses careerists in politics, using metaphors of bulls and horses to describe vitality, which is a separate topic.

A new nonprofit organization has been established with the goal of streamlining gene therapy for rare diseases, which are often overlooked by pharmaceutical companies, aiming to make treatment more routine than bespoke.

Major pharmaceutical companies are investing in the development of drugs based on hallucinogenic substances, including toad venom and psychedelic mushrooms, with the Donald Trump administration reportedly giving the green light for these new medications.

An analysis explores why major pharmaceutical companies are unlikely to develop affordable anti-aging drugs, despite scientific hypotheses suggesting generic drugs like metformin and rapamycin could slow aging.

Pharmaceutical companies in Austria are increasingly worried about future conditions, rating the country's business environment as only average and identifying growing risks to their economic development due to location, pricing policies, and US regulations.

Two pharmaceutical companies announced that their jointly developed heart disease drug failed its Phase III trial, leading to a significant loss of $27 billion in market value for a major drugmaker.

A House committee has launched an investigation into several pharmaceutical companies, including Eli Lilly, Bristol, Merck, and AbbVie, regarding their clinical trials in China, particularly those tied to military-linked hospitals and facilities in Xinjiang, citing biotech risks.

Pharmaceutical companies are reportedly acquiring biotechnology firms in a panicked response to market conditions. This trend suggests a strategic shift within the industry as larger companies seek to integrate biotech innovations.

A weekly roundup highlights significant developments in the healthcare sector, focusing on key updates from pharmaceutical companies Merck, Moderna, and Biogen.

The U.S. government is examining whether German laws aimed at reducing drug costs unfairly burden American pharmaceutical companies, potentially leading to new sanctions.

A small company that started in a Lisbon basement has grown to become one of Portugal's largest employers of PhDs and a partner to 19 of the world's top 20 pharmaceutical companies, demonstrating significant global impact.

Czech Health Minister Adam Vojtěch has issued a warning that a proposed new EU directive, which would mandate pharmaceutical companies to financially contribute to wastewater treatment, could lead to increased drug prices. He also expressed concerns that this measure might pressure manufacturers to relocate drug production outside the European Union.

New weight-loss drugs have seen global success, but many patients regain significant weight after discontinuing treatment. Pharmaceutical companies are now working on developing long-term solutions to help users maintain their results.

Pharmaceutical companies Merck and Gilead have reported positive outcomes from their Phase 3 clinical trials for a new combination pill designed to treat HIV.

A commentary suggests that Germany's policies, which have led two major pharmaceutical companies to reduce their investments, serve as a cautionary tale for Switzerland regarding the potential for driving away pharmaceutical corporations unnecessarily.

Bristol Myers Squibb received first place for its Cancer Survivor Clinics at the EEFAM Excellence Awards. AbbVie also earned a Gold Excellence Award at the EEFAM 2026 for its Oncology Innovation.

A survey by 'Capital Health' identifies the top 10 pharmaceutical companies in Bulgaria for 2025, with MSD leading in prescription drug sales.

As part of the 'Choose France' initiative, pharmaceutical companies GSK, Sandoz, and Stallergenes are investing 600 million euros to modernize or expand their existing production sites in the health sector.

Former President Trump's proposed drug pricing policies are anticipated to potentially reduce the profits of pharmaceutical companies, raising questions about the future of pharma stocks.

Approximately 90,000 Finns used semaglutide for obesity last year, with Finns spending 66 million of their own money on obesity medications, while pharmaceutical companies' attempts to get obesity drugs covered by Kela reimbursements have been unsuccessful.

Rocket Pharmaceuticals reported a Q1 2026 net loss of $47.6 million, while Compass Therapeutics also announced a net loss of $18.3 million for the same quarter. Both pharmaceutical companies disclosed their financial results.

Biopharmaceutical companies are exploring partnerships and research and development opportunities in China and other international markets.

Specialists in Moldova are increasingly debating changes to pharmaceutical market legislation, questioning whether current laws protect the interests of patients or individual pharmaceutical companies and aiming to prevent monopolies.

Conspiracy theories regarding the Hantavirus are rapidly spreading across the internet, linking the virus to various entities from pharmaceutical companies and The Simpsons to Bill Gates and Jeffrey Epstein. These theories are gaining traction despite a low number of actual infections.

France's National Agency for the Safety of Medicine and Health Products (ANSM) has sanctioned pharmaceutical companies Novo Nordisk and Eli Lilly, ruling that their 'awareness initiatives' were in fact covert product promotions.

An article from The Daily Star discusses the critical role of responsibility in the leadership of pharmaceutical companies, likely emphasizing ethical practices and industry accountability.

A new global report by PatientViewTM, "Corporate Reputation of Pharmaceutical Products, 2025/2026," indicates a decline in the reputation of pharmaceutical companies, particularly those perceived as distant from patients during challenging times.

Pharmaceutical companies Novo Nordisk and Eli Lilly have been fined hundreds of thousands of euros for failing to comply with advertising restrictions for prescription-only anti-obesity medications.

Pharmaceutical companies in Germany are expressing strong opposition to Minister Warken's proposed health reforms, warning that the changes could prevent new medications from reaching patients and lead to job losses.

Indian pharmaceutical companies are significantly impacting the global weight loss drug market by introducing generic versions that reduce treatment costs by up to 70 percent.

Pharmaceutical companies Amgen and AstraZeneca have begun real-time drug trials, coinciding with the FDA's use of artificial intelligence to speed up drug development.

An analysis explores whether Bristol Myers Squibb represents the best value investment among major pharmaceutical companies. The article likely delves into the company's financials, pipeline, and market position.

Analysts are assessing the investment potential of several healthcare and pharmaceutical companies, including Eli Lilly, IGC Pharma, and 60 Degrees Pharmaceuticals. They are providing insights and recommendations for investors considering these stocks.

Seventeen major pharmaceutical companies have agreed to participate in a US initiative aimed at reducing the cost of prescription medications.

China's State Council has published new guidelines on innovative drug pricing, described by analysts as the most significant in a decade. The new rules aim to reward drug innovation and ease pricing tensions for both domestic and multinational pharmaceutical companies.

An article argues that the pursuit of a cancer cure should not be constrained by the interests and influence of large pharmaceutical companies.

The Hellenic Association of Pharmaceutical Companies (SFEE) expressed disappointment with Greece's investment clawback decree for 2026–2027, stating that none of their proposals were included and that it hinders innovation.

Artificial intelligence is being leveraged by pharmaceutical companies to reduce the time and cost of drug development by up to 35%, offering a solution to the ongoing patent crisis.

Health Secretary Teodoro Herbosa announced that pharmaceutical companies in the Philippines have committed to not increasing medicine prices until June, citing stability in prices and inventory despite the ongoing Middle East crisis.

The European Union has given its clearance for the $4.8 billion merger between US pharmaceutical companies BioMarin and Amicus.

Holly Springs, North Carolina, is attracting pharmaceutical companies with features that once characterized Switzerland, transforming North Carolina from America's poorest state to its most business-friendly.

China has given its approval for an innovative breast cancer therapy developed jointly by pharmaceutical companies Daiichi Sankyo and AstraZeneca, expanding treatment options for patients.

This week's notable healthcare headlines focus on key developments concerning pharmaceutical companies such as Eli Lilly, which is expanding Zepbound access, along with Novo Nordisk and Novartis.

Pharmaceutical companies UNI-PHARMA and InterMed have been certified as Top Employers 2026 in Greece by the independent international organization Top Employers Institute for the fourth consecutive year.

Chinese contract drug makers – including WuXi AppTec, WuXi Biologics and WuXi XDC – face a less certain long-term revenue outlook as US pharmaceutical companies bring production in-house and reconfigure supply chains amid rising US-China tensions. While near-term earnings remained largely locked in, visibility beyond that was limited, according to Cui Cui, head of healthcare research for Asia at Jefferies. “Earnings visibility for 2026 and 2027 is still very strong – revenue momentum is large...

The director of the newspaper Página Um has been acquitted of defamation charges, with the court deeming the accusation 'totally unfounded' in a case stemming from articles about alleged financial links between doctors and pharmaceutical companies during the Covid-19 pandemic.

Subscribe to the "Kapital Zdrave" newsletter here to follow the most current processes in the health sector.

Several financial firms have issued new ratings, price targets, or coverage initiations for biotech and pharmaceutical companies including Beam Therapeutics, Krystal Biotech, 4D Molecular Therapeutics, BioMarin Pharmaceutical, Vertex Pharmaceuticals, CRISPR Therapeutics AG, Regeneron Pharmaceuticals, and UniQure.

Indian pharmaceutical companies Eris Lifesciences and Natco Pharma have entered into an agreement concerning the drug Semaglutide.

Multiple biotech and pharmaceutical companies, including Legend Biotech, Corcept Therapeutics, and Ultragenyx, have released updates on their drug pipelines, clinical trial data, and regulatory interactions, impacting market outlook.